These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 16415544)

  • 1. The effect of dehydroepiandrosterone sulfate (DHEAS) on myotonia: intracellular studies.
    Nakazora H; Kurihara T
    Intern Med; 2005 Dec; 44(12):1247-51. PubMed ID: 16415544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dehydroepiandrosterone sulfate (DHEAS) therapy for myotonic dystrophy type 1 and myotonia.
    Sugino M
    Intern Med; 2005 Dec; 44(12):1213-4. PubMed ID: 16415539
    [No Abstract]   [Full Text] [Related]  

  • 3. [Intracellular recording of myotonia in mdx mouse and the effect of Ca antagonist in myotonia].
    Kishi M; Kurihara T; Uchida H; Kinoshita M
    Rinsho Shinkeigaku; 1989 May; 29(5):563-7. PubMed ID: 2791403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A pilot study of dehydroepiandrosterone sulfate in myotonic dystrophy.
    Sugino M; Ohsawa N; Ito T; Ishida S; Yamasaki H; Kimura F; Shinoda K
    Neurology; 1998 Aug; 51(2):586-9. PubMed ID: 9710041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Myotonia and channelopathy].
    Kurihara T
    Rinsho Shinkeigaku; 1999 Dec; 39(12):1219-21. PubMed ID: 10791081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The anti-convulsants lacosamide, lamotrigine, and rufinamide reduce myotonia in isolated human and rat skeletal muscle.
    Skov M; de Paoli FV; Nielsen OB; Pedersen TH
    Muscle Nerve; 2017 Jul; 56(1):136-142. PubMed ID: 27783415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of Na+ channel inactivation by anemone toxin (ATX II) mimics the myotonic state in hyperkalaemic periodic paralysis.
    Cannon SC; Corey DP
    J Physiol; 1993 Jul; 466():501-20. PubMed ID: 8105077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of temperature reduction on myotonia in rat skeletal muscles in vitro.
    Fanning L; MacDermott M
    Clin Sci (Lond); 1997 Jun; 92(6):587-92. PubMed ID: 9205419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of secondary effects of hyperexcitability by proteomic profiling of myotonic mouse muscle.
    Staunton L; Jockusch H; Wiegand C; Albrecht T; Ohlendieck K
    Mol Biosyst; 2011 Aug; 7(8):2480-9. PubMed ID: 21629954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibiting persistent inward sodium currents prevents myotonia.
    Hawash AA; Voss AA; Rich MM
    Ann Neurol; 2017 Sep; 82(3):385-395. PubMed ID: 28833464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Equine muscular dystrophy with myotonia.
    Montagna P; Liguori R; Monari L; Strong PN; Riva R; Di Stasi V; Gandini G; Cipone M
    Clin Neurophysiol; 2001 Feb; 112(2):294-9. PubMed ID: 11165532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contractile and EMG studies of murine myotonia (mto) and muscular dystrophy (dy/dy).
    Entrikin RK; Abresch RT; Sharman RB; Larson DB; Levine NA
    Muscle Nerve; 1987 May; 10(4):293-8. PubMed ID: 3587263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Homologation of mexiletine alkyl chain and stereoselective blockade of skeletal muscle sodium channels.
    Duranti A; Franchini C; Lentini G; Loiodice F; Tortorella V; De Luca A; Pierno S; Conte Camerino D
    Eur J Med Chem; 2000 Jan; 35(1):147-56. PubMed ID: 10733611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo evaluation of antimyotonic efficacy of β-adrenergic drugs in a rat model of myotonia.
    Desaphy JF; Costanza T; Carbonara R; Conte Camerino D
    Neuropharmacology; 2013 Feb; 65():21-7. PubMed ID: 23000075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myotonia in the rat diaphragm preparation caused by the sulfhydryl inhibiting para-substituted mercuribenzoates.
    Röed A
    Acta Physiol Scand; 1982 May; 115(1):31-8. PubMed ID: 7136802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and electrophysiological observations in patients with myotonic muscle disease and the therapeutic effect of N-propyl-ajmalin.
    Birnberger KL; Rüdel R; Struppler A
    J Neurol; 1975 Sep; 210(2):99-110. PubMed ID: 51920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific binding and effects of dehydroepiandrosterone sulfate (DHEA-S) on skeletal muscle cells: possible implication for DHEA-S replacement therapy in patients with myotonic dystrophy.
    Tsuji K; Furutama D; Tagami M; Ohsawa N
    Life Sci; 1999; 65(1):17-26. PubMed ID: 10403489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mexiletine is an effective antimyotonia treatment in myotonic dystrophy type 1.
    Logigian EL; Martens WB; Moxley RT; McDermott MP; Dilek N; Wiegner AW; Pearson AT; Barbieri CA; Annis CL; Thornton CA; Moxley RT
    Neurology; 2010 May; 74(18):1441-8. PubMed ID: 20439846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myotonia and neuromuscular transmission in the mouse.
    Költgen D; Brinkmeier H; Jockusch H
    Muscle Nerve; 1991 Aug; 14(8):775-80. PubMed ID: 1653899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuromuscular excitability changes produced by sustained voluntary contraction and response to mexiletine in myotonia congenita.
    Ginanneschi F; Mignarri A; Lucchiari S; Ulzi G; Comi GP; Rossi A; Dotti MT
    Neurophysiol Clin; 2017 Jun; 47(3):247-252. PubMed ID: 28153715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.